The present invention relates to novel heterocyclic compounds that inhibit phosphodiesterase type 4 (PDE 4). The compounds are useful for treating inflammatory conditions, diseases of the central nervous systems and insulin resistant diabetes.
本发明涉及一种新型
杂环化合物,可抑制
磷酸二酯酶4型(PDE 4)。这些化合物可用于治疗炎症性疾病、中枢神经系统疾病和
胰岛素抵抗性糖尿病。